DEXCOM INC — Director's Dealing 2015

Nov 24, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2015-11-23

Reporting Person: Balo Andrew K (EVP, Clinical, Regulatory)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-11-23	Common Stock	M	5200.0	$3.19	Acquired	118357	Direct
2015-11-23	Common Stock	S	5200.0	$86.5	Disposed	113157	Direct
2015-11-24	Common Stock	M	4800.0	$3.19	Acquired	117957	Direct
2015-11-24	Common Stock	S	4800.0	$86.3612	Disposed	113157	Direct
2015-11-24	Common Stock	G	5477.0	$0.0	Disposed	107680	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-11-23	Non-Qualified Stock Option (right to buy)	$3.19	M	5200.0	Disposed	2018-12-11	Common Stock (5200)	Direct
2015-11-24	Non-Qualified Stock Option (right to buy)	$3.19	M	4800.0	Disposed	2018-12-11	Common Stock (4800)	Direct

Footnotes

F1: Included in this number are 80,834 unvested restricted stock units, 47,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018, 25,000 of which were granted on March 8, 2014 and shall vest through March 8, 2017, and 8,334 of which were granted on March 11, 2013 and shall vest through March 11, 2016.

F2: This transaction represents a gift made by the reporting person. This is not a market transaction, thus no price has been reported.